BIOMAT Database Logo BIOMAT Database Logo

Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases. 1988

T G Theander, and A Kharazmi, and B K Pedersen, and L D Christensen, and N Tvede, and L K Poulsen, and N Odum, and M Svenson, and K Bendtzen
Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.

This study was undertaken to determine the effect of Pseudomonas aeruginosa alkaline protease (AP) and elastase (ELA) on human lymphocyte function. AP at 50 micrograms/ml and ELA at 12 micrograms/ml caused a 50% inhibition of phytohemagglutinin-induced proliferation. There was no difference in the effect of proteases on CD4- and CD8-positive cells. To determine the effect of proteases on interleukin-2 (IL-2)-induced cell proliferation, the proteases and IL-2 were added to the IL-2-dependent CTLL-2 cell line. AP and ELA inhibited the proliferation of these cells. When IL-2 was added in excess, the inhibition was partly reversed. ELA at 10 micrograms/ml cleaved IL-2, as judged by size chromatography of a reaction mixture containing 125I-labeled IL-2 and the proteases. The ELA-digested IL-2 exhibited a reduced binding capacity to IL-2 receptors on the lymphocytes. Furthermore, treatment of phytohemagglutinin-stimulated lymphocytes with AP and ELA resulted in inhibition of binding of intact IL-2 to IL-2 receptors on the stimulated lymphocytes. These results indicated that P. aeruginosa-derived enzymes are able to interfere with human lymphocyte function in vitro and that this effect might be due to cleavage of IL-2.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D010196 Pancreatic Elastase A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, and albumin. EC 3.4.21.36. Elastase,Pancreatopeptidase,Elastase I,Pancreatic Elastase I,Elastase I, Pancreatic,Elastase, Pancreatic
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D010835 Phytohemagglutinins Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture. Kidney Bean Lectin,Kidney Bean Lectins,Lectins, Kidney Bean,Phaseolus vulgaris Lectin,Phaseolus vulgaris Lectins,Phytohemagglutinin,Hemagglutinins, Plant,Lectin, Kidney Bean,Lectin, Phaseolus vulgaris,Lectins, Phaseolus vulgaris,Plant Hemagglutinins
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T G Theander, and A Kharazmi, and B K Pedersen, and L D Christensen, and N Tvede, and L K Poulsen, and N Odum, and M Svenson, and K Bendtzen
In vitro inhibition of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments.
July 1983, Infection and immunity,
T G Theander, and A Kharazmi, and B K Pedersen, and L D Christensen, and N Tvede, and L K Poulsen, and N Odum, and M Svenson, and K Bendtzen
Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases.
May 1993, Investigative ophthalmology & visual science,
T G Theander, and A Kharazmi, and B K Pedersen, and L D Christensen, and N Tvede, and L K Poulsen, and N Odum, and M Svenson, and K Bendtzen
Suppression of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments.
January 1988, Israel journal of medical sciences,
T G Theander, and A Kharazmi, and B K Pedersen, and L D Christensen, and N Tvede, and L K Poulsen, and N Odum, and M Svenson, and K Bendtzen
Suppression of lymphocyte proliferation by Pseudomonas aeruginosa: mediation by Pseudomonas-activated suppressor monocytes.
June 1985, Infection and immunity,
T G Theander, and A Kharazmi, and B K Pedersen, and L D Christensen, and N Tvede, and L K Poulsen, and N Odum, and M Svenson, and K Bendtzen
Inhibition of mitogen-induced lymphocyte proliferation by ouabain: interference with interleukin 2 production and interleukin 2 action.
September 1983, Journal of immunology (Baltimore, Md. : 1950),
T G Theander, and A Kharazmi, and B K Pedersen, and L D Christensen, and N Tvede, and L K Poulsen, and N Odum, and M Svenson, and K Bendtzen
Inhibition of lymphocyte transformation by a factor from Pseudomonas aeruginosa.
January 1983, International journal of tissue reactions,
T G Theander, and A Kharazmi, and B K Pedersen, and L D Christensen, and N Tvede, and L K Poulsen, and N Odum, and M Svenson, and K Bendtzen
Inhibition of lymphocyte motility by interleukin 2.
December 1986, Clinical and experimental immunology,
T G Theander, and A Kharazmi, and B K Pedersen, and L D Christensen, and N Tvede, and L K Poulsen, and N Odum, and M Svenson, and K Bendtzen
Activation of human pro-urokinase by unrelated proteases secreted by Pseudomonas aeruginosa.
May 2010, The Biochemical journal,
T G Theander, and A Kharazmi, and B K Pedersen, and L D Christensen, and N Tvede, and L K Poulsen, and N Odum, and M Svenson, and K Bendtzen
Stimulation of secretion into human and feline airways by Pseudomonas aeruginosa proteases.
May 1991, Journal of applied physiology (Bethesda, Md. : 1985),
T G Theander, and A Kharazmi, and B K Pedersen, and L D Christensen, and N Tvede, and L K Poulsen, and N Odum, and M Svenson, and K Bendtzen
[Extradiol cleavage of 2-aminophenol by pyrocatechase from Pseudomonas aeruginosa 2X].
January 1984, Mikrobiologicheskii zhurnal,
Copied contents to your clipboard!